These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 36708970)

  • 1. Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and Cholangiocarcinoma.
    Ying F; Chan MSM; Lee TKW
    Cell Mol Gastroenterol Hepatol; 2023; 15(4):985-999. PubMed ID: 36708970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma progression and therapeutic resistance.
    Ravichandra A; Bhattacharjee S; Affò S
    Adv Cancer Res; 2022; 156():201-226. PubMed ID: 35961700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Role of Cancer-Associated Fibroblasts in Progression and Treatment of Hepatocellular Carcinoma.
    Akkız H
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CAFs shape myeloid-derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma through 5-lipoxygenase.
    Lin Y; Cai Q; Chen Y; Shi T; Liu W; Mao L; Deng B; Ying Z; Gao Y; Luo H; Yang X; Huang X; Shi Y; He R
    Hepatology; 2022 Jan; 75(1):28-42. PubMed ID: 34387870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SERPINE1: Role in Cholangiocarcinoma Progression and a Therapeutic Target in the Desmoplastic Microenvironment.
    Czekay RP; Higgins CE; Aydin HB; Samarakoon R; Subasi NB; Higgins SP; Lee H; Higgins PJ
    Cells; 2024 May; 13(10):. PubMed ID: 38786020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatial multiomics reveals a subpopulation of fibroblasts associated with cancer stemness in human hepatocellular carcinoma.
    Jing SY; Liu D; Feng N; Dong H; Wang HQ; Yan X; Chen XF; Qu MC; Lin P; Yi B; Feng F; Chen L; Wang HY; Li H; He YF
    Genome Med; 2024 Aug; 16(1):98. PubMed ID: 39138551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-associated fibroblasts promote the stemness of CD24
    Li Y; Wang R; Xiong S; Wang X; Zhao Z; Bai S; Wang Y; Zhao Y; Cheng B
    J Mol Med (Berl); 2019 Feb; 97(2):243-255. PubMed ID: 30564864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity, crosstalk, and targeting of cancer-associated fibroblasts in cholangiocarcinoma.
    Cantallops Vilà P; Ravichandra A; Agirre Lizaso A; Perugorria MJ; Affò S
    Hepatology; 2024 Apr; 79(4):941-958. PubMed ID: 37018128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression pattern of cancer-associated fibroblast and its clinical relevance in intrahepatic cholangiocarcinoma.
    Zhang XF; Dong M; Pan YH; Chen JN; Huang XQ; Jin Y; Shao CK
    Hum Pathol; 2017 Jul; 65():92-100. PubMed ID: 28457731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The landscape of cancer-associated fibroblasts in colorectal cancer liver metastases.
    Giguelay A; Turtoi E; Khelaf L; Tosato G; Dadi I; Chastel T; Poul MA; Pratlong M; Nicolescu S; Severac D; Adenis A; Sgarbura O; Carrère S; Rouanet P; Quenet F; Ychou M; Pourquier D; Colombo PE; Turtoi A; Colinge J
    Theranostics; 2022; 12(17):7624-7639. PubMed ID: 36438498
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer-Associated Fibroblasts and Extracellular Matrix: Therapeutical Strategies for Modulating the Cholangiocarcinoma Microenvironment.
    Minini M; Fouassier L
    Curr Oncol; 2023 Apr; 30(4):4185-4196. PubMed ID: 37185432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance.
    Liu J; Li P; Wang L; Li M; Ge Z; Noordam L; Lieshout R; Verstegen MMA; Ma B; Su J; Yang Q; Zhang R; Zhou G; Carrascosa LC; Sprengers D; IJzermans JNM; Smits R; Kwekkeboom J; van der Laan LJW; Peppelenbosch MP; Pan Q; Cao W
    Cell Mol Gastroenterol Hepatol; 2021; 11(2):407-431. PubMed ID: 32932015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-associated fibroblasts in hepatocellular carcinoma.
    Kubo N; Araki K; Kuwano H; Shirabe K
    World J Gastroenterol; 2016 Aug; 22(30):6841-50. PubMed ID: 27570421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations.
    Affo S; Nair A; Brundu F; Ravichandra A; Bhattacharjee S; Matsuda M; Chin L; Filliol A; Wen W; Song X; Decker A; Worley J; Caviglia JM; Yu L; Yin D; Saito Y; Savage T; Wells RG; Mack M; Zender L; Arpaia N; Remotti HE; Rabadan R; Sims P; Leblond AL; Weber A; Riener MO; Stockwell BR; Gaublomme J; Llovet JM; Kalluri R; Michalopoulos GK; Seki E; Sia D; Chen X; Califano A; Schwabe RF
    Cancer Cell; 2021 Jun; 39(6):866-882.e11. PubMed ID: 33930309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulating PCGF4/BMI1 Stability Is an Efficient Metastasis-Regulatory Strategy Used by Distinct Subtypes of Cancer-Associated Fibroblasts in Intrahepatic Cholangiocarcinoma.
    Hu J; Xu H; Ma X; Bai M; Zhou Y; Miao R; Wang F; Li X; Cheng B
    Am J Pathol; 2024 Jul; 194(7):1388-1404. PubMed ID: 38670529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-associated fibroblasts in cholangiocarcinoma.
    Vaquero J; Aoudjehane L; Fouassier L
    Curr Opin Gastroenterol; 2020 Mar; 36(2):63-69. PubMed ID: 31934895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative analyses of bulk and single-cell transcriptomics reveals the infiltration and crosstalk of cancer-associated fibroblasts as a novel predictor for prognosis and microenvironment remodeling in intrahepatic cholangiocarcinoma.
    Zhong YJ; Luo XM; Liu F; He ZQ; Yang SQ; Ma WJ; Wang JK; Dai YS; Zou RQ; Hu YF; Lv TR; Li FY; Hu HJ
    J Transl Med; 2024 May; 22(1):422. PubMed ID: 38702814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma.
    Mertens JC; Fingas CD; Christensen JD; Smoot RL; Bronk SF; Werneburg NW; Gustafson MP; Dietz AB; Roberts LR; Sirica AE; Gores GJ
    Cancer Res; 2013 Jan; 73(2):897-907. PubMed ID: 23221385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.